10 most recent publications out of a total of 247
Chang Q, Harvey K, Akard L, Thompson J, Dugan MJ, English D, Jansen
J. Differences in CD34+ cell subpopulations between human bone
marrow and mobilized peripheral blood as determined with counterflow
centrifugal elutriation. Experimental Hematology 25: 423-431, 1997.
Harvey K, Higgins N, Akard L, Chang Q, Jansen J, Thompson
J, Dugan M, Rizzo MT, English D. Lineage commitment of HLA-DR/CD38-defined
progenitor cell subpopulations in bone marrow and mobilized peripheral
blood assessed by four-color immuno-fluorescence. Journal of Hematotherapy
6:243-252, 1997.
Chang Q, Harvey K, Akard L, Thompson J, Dugan M, English D, and Jansen
J. Counterflow centrifugal elutriation as a method of T cell depletion
may cause loss of immature CD34+ cells. Bone Marrow Transplantation
19:1145-1150, 1997.
Dao DY, Chang Q, Liu C, Farris K, Harvey K, McGann LE, English D,
Jansen J, Critser JK.Fundamental cryobiology of human hematopoietic
progenitor cells.I. Osmotic characteristics and volume distribution.
Cryobiology 36: 40-48, 1998
Abdel-Mageer A, Graham-Pole J, Del Rosario MLU, Longmate J, Ochoa
S, Amylon M, Elfenbuin GJ, Janiec J, Jansen J, Lazarus HM.
Comparison of two doses of intravenous immunoglobulin after allogeneic
bone marrow transplants. Bone Marrow Transplantation 23: 929-932,
1999
Jansen J, Thompson EM, Hanks S, Greenspan AR, Thompson JM,
Dugan MJ, Akard LP. Hematopoietic growth factor after autologous peripheral
blood transplantation: comparison of G-CSF and GM-CSF. Bone Marrow
Transplantation 23: 1251-1256, 1999
Akard LP, Thompson JM, Dugan MJ, Wiemann M, Greenspan A, Hanks S,
Swinney M, Nyhuis A, Jansen J. Matched pair analysis of hematopoietic
progenitor cell mobilization using G-CSF versus cyclophosphamide,
etoposide, and G-CSF: enhanced CD34+ cell collections are not necessarily
cost effective. Biology of Blood and Marrow Transplantation 5:
379-385,1999.
Chang Q, Harvey K, Akard L, Thompson J, Hanks S, Dugan M, Jansen
J. Comparison of the distribution of progenitor cells in G-CSF
mobilized peripheral blood and steady-state bone marrow after counterflow
centrifugal elutriation. Biology of Blood and Marrow Transplantation
5:328-335, 1999
List AF, Maziarz R, Stiff P, Jansen J, Liesveld J, Andrrews
F, Shcuster M, Wolff S, Litzow M, Karanes C, Dahlberg S, Bianco JA,
Singer JW. A randomized placebo-controlled tial of lisofylline in
HLA-identical, sibling donor, allogeneic bone marrow transplant recipients.
Bone Marrow Transplantation (in press).
Wolff SN, List A, Ahmed T, Godder K, Herzig R, Jansen J, Karanes
C, Kawahara K, Kaizer H, Liesveld J, Litzow MR, Maziarz RT, McCarthy
P, Schuster M, Stiff P, Territo M, Yanovich S, Greer JP, Stein RS,
Goodman SA, Dahlberg S, Kirkhart B, Paradise C, Singer JW. Lisofylline.
A phase III double-blind randomized trial for the prevention of infection
and acute GVHD after matched sibling allogeneic BMT. Biology of
Blood and Marrow Transplantation (in press)